| Product NDC: | 55648-630 |
| Proprietary Name: | ADENOSINE |
| Non Proprietary Name: | ADENOSINE |
| Active Ingredient(s): | 3 mg/mL & nbsp; ADENOSINE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55648-630 |
| Labeler Name: | WOCKHARDT LIMITED |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090220 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090720 |
| Package NDC: | 55648-630-07 |
| Package Description: | 10 SYRINGE, GLASS in 1 CARTON (55648-630-07) > 2 mL in 1 SYRINGE, GLASS (55648-630-01) |
| NDC Code | 55648-630-07 |
| Proprietary Name | ADENOSINE |
| Package Description | 10 SYRINGE, GLASS in 1 CARTON (55648-630-07) > 2 mL in 1 SYRINGE, GLASS (55648-630-01) |
| Product NDC | 55648-630 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ADENOSINE |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090720 |
| Marketing Category Name | ANDA |
| Labeler Name | WOCKHARDT LIMITED |
| Substance Name | ADENOSINE |
| Strength Number | 3 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |